Catalyst Pharmaceuticals, Inc. (CPRX)
NASDAQ: CPRX · Real-Time Price · USD
21.15
-0.24 (-1.12%)
At close: Nov 20, 2024, 4:00 PM
21.20
+0.05 (0.24%)
Pre-market: Nov 21, 2024, 7:28 AM EST
Catalyst Pharmaceuticals Market Cap
Catalyst Pharmaceuticals has a market cap or net worth of $2.52 billion as of November 21, 2024. Its market cap has increased by 84.19% in one year.
Market Cap
2.52B
Enterprise Value
2.08B
1-Year Change
84.19%
Ranking
Category
Stock Price
$21.15
Market Cap Chart
Since December 15, 2006, Catalyst Pharmaceuticals's market cap has increased from $69.00M to $2.52B, an increase of 3,555.99%. That is a compound annual growth rate of 22.21%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 2.52B | 40.76% |
| Dec 29, 2023 | 1.79B | -7.42% |
| Dec 30, 2022 | 1.94B | 177.28% |
| Dec 31, 2021 | 698.10M | 101.65% |
| Dec 31, 2020 | 346.20M | -10.40% |
| Dec 31, 2019 | 386.40M | 95.84% |
| Dec 31, 2018 | 197.30M | -40.80% |
| Dec 29, 2017 | 333.30M | 283.10% |
| Dec 30, 2016 | 87.00M | -57.12% |
| Dec 31, 2015 | 202.90M | -1.17% |
| Dec 31, 2014 | 205.30M | 94.41% |
| Dec 31, 2013 | 105.60M | 599.34% |
| Dec 31, 2012 | 15.10M | -52.66% |
| Dec 30, 2011 | 31.90M | 66.15% |
| Dec 31, 2010 | 19.20M | 68.42% |
| Dec 31, 2009 | 11.40M | -54.94% |
| Dec 31, 2008 | 25.30M | -41.44% |
| Dec 31, 2007 | 43.20M | -28.60% |
| Dec 29, 2006 | 60.50M | -12.32% |
View and export this data all the way back to 2006.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| TransMedics Group | 2.59B |
| Zai Lab | 2.58B |
| Janux Therapeutics | 2.57B |
| Apogee Therapeutics | 2.56B |
| Belite Bio | 2.53B |
| QuidelOrtho | 2.52B |
| Privia Health Group | 2.49B |
| Iovance Biotherapeutics | 2.48B |